AskBio Publishes Full Phase 1b Results of AB-1005 Gene Therapy for Parkinson’s Disease
AskBio Publishes Complete Phase 1b Trial Results of AB-1005 Gene Therapy for Parkinson’s Disease in Leading Neurology Journal Asklepios BioPharmaceutical, Inc. (AskBio), a pioneering gene therapy company that operates as…
Biogen and City Therapeutics Partner on Novel RNAi Therapy Research
Biogen and City Therapeutics Forge Strategic Partnership to Pioneer Next-Generation RNAi-Based Therapies Targeting Central Nervous System Diseases Biogen,a global leader in neuroscience and neurodegenerative disease research, and City Therapeutics, Inc.,…
Takeda and Nature Open 2026 Innovators in Science Award Applications
Takeda and Nature Open Applications for 2026 Innovators in Science Award to Celebrate Emerging Scientific Talent Takeda Pharmaceutical Company Limited has officially opened the application window for its prestigious Innovators…
Novartis Launches Tender Offer to Acquire Regulus Therapeutics
Novartis Launches Tender Offer to Acquire Regulus Therapeutics in $7 Per Share Deal, with Potential Bonus Payout Linked to Regulatory Milestone In a strategic move that underscores its continued investment…
CHMP Recommends EU Approval of Imfinzi as First Perioperative Immunotherapy for Bladder Cancer
AstraZeneca’s Imfinzi Gains CHMP Backing as First Perioperative Immunotherapy for Muscle-Invasive Bladder Cancer in the EU AstraZeneca has announced a significant regulatory milestone for its cancer immunotherapy, Imfinzi (durvalumab), with…
AbbVie Showcases Broad Oncology Data in Solid Tumors and Blood Cancers at ASCO 2025
AbbVie Highlights Expanding Oncology Pipeline at ASCO 2025 with New Data Across Challenging Solid Tumors and Blood Cancers AbbVie has announced a significant presence at the upcoming 2025 American Society…
Eli Lilly Bolsters Pain Management Portfolio with SiteOne Therapeutics Acquisition
Eli Lilly to Acquire SiteOne Therapeutics in $1 Billion Deal to Advance Non-Opioid Pain Therapy In a strategic move aimed at strengthening its neuroscience and pain management portfolio, Eli Lilly…
Lupin and SteinCares Announce License and Supply Partnership for Ranibizumab Across Latin America
Lupin and SteinCares Forge Strategic License and Supply Agreement to Commercialize Ranibizumab Biosimilar Across Latin America Global pharmaceutical leader Lupin Limited (Lupin) has officially announced the signing of a significant…
WHO Issues New Guideline to Expand Global Access to Controlled Medications
WHO Launches Landmark Guideline to Bridge Global Gaps in Access to Controlled Medicines In a bold step toward improving global health equity, the World Health Organization (WHO) unveiled a new…
China Approves In-House Anti-Insomnia Drug DAYVIGO
Eisai’s Lemborexant (DAYVIGO®) Receives Regulatory Approval in China for the Treatment of Insomnia Eisai Co., Ltd., a leading global pharmaceutical company headquartered in Tokyo and led by CEO Haruo Naito,…
Advancing the Future of Care with Pompe Patients
Partnering for Progress: How Astellas and the Pompe Disease Community Are Shaping the Future Together Pompe disease is a rare, inherited, and progressively debilitating disorder that profoundly affects the lives…
Driving Change in Oncology: Pivotal Data and Global Trends at #ASCO25
Practice-Changing Data, Innovative Modalities, and Global Impact Headline ASCO 2025 The oncology community is converging in Chicago this week for the highly anticipated 2025 Annual Meeting of the American Society…